June 25, 2018 8:15 AM ET

Life Sciences Tools and Services

Company Overview of Yumanity Therapeutics Inc.

Key Executives for Yumanity Therapeutics Inc.

NameBoard RelationshipsTitleAge
N. Anthony Coles Jr.133 RelationshipsChairman and Chief Executive Officer57
Chee Yeun Chung Ph.D.No RelationshipsScientific Co-Founder & Associate Director of Discovery Biology--
Vikram Khurana M.D., Ph.D.No RelationshipsScientific Co-Founder & Senior Advisor of Discovery Biology--
Daniel Tardiff Ph.D.No RelationshipsScientific Co-Founder & Associate Director of Discovery Biology--
John G. Cox 17 RelationshipsExecutive Vice President of Therapeutic Operations, Biogen54
View More Key Executives

Yumanity Therapeutics Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
N. Anthony Coles Jr. 133 RelationshipsCRISPR Therapeutics AG57
Joel S. Marcus CPA, J.D. 335 RelationshipsAlexandria Venture Investments, LLC69
View All Board Members

Yumanity Therapeutics Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
Yumanity Therapeutics Inc. CEO Compensation
Industry Average


EVIO, Inc. Appoints Donald R. Gibbs as Independent Director and Chair of the Audit Committee
June 21, 2018 12:00 PM ET
Biological Dynamics Announces Executive Changes
June 20, 2018 1:00 PM ET
EVIO Inc. Appoints Felipe Campusano to Board of Directors
June 19, 2018 1:00 PM ET
ProSciento, Inc Appoints Carine Beysen as Senior Director of Clinical Research Innovation Services
June 19, 2018 10:30 AM ET
Jean Philibert Joins 10x Genomics as Chief People Officer
June 14, 2018 12:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Yumanity Therapeutics Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.